Eden Research Plc · LSE:EDEN

Eden Research — Investor Presentation (June 2021)

29 slides from Eden Research's investor presentation, Jun 30, 2021

  1. Slide 1: Eden Research plc Investor Conference

    Eden Research plc Investor Conference 30th June 2021 Hosted from Milton Park, Oxfordshire, United Kingdom

  2. Slide 2: Eden Research plc is an AIM-quoted company focused on sustainable biopesticides

    2 Eden Research plc is an AIM-quoted company focused on sustainable biopesticides and plastic-free encapsulation technology for use in the global crop protection, animal health and consumer products industries.

  3. Slide 3: About Us Key Statistics

    About Us Eden is the only UK quoted (AIM: EDEN) company focused on biopesticides for sustainable agriculture Key • Intellectual property and expertise in plant-derived sustainable chemistry and delivery technologies • Proven products Statistics 16 19 New local distributorships Countries have granted

  4. Slide 4: Industry Applications

    Industry Applications We work globally through CROP ANIMAL CONSUMER multi-national and local PROTECTION HEALTH PRODUCTS partnerships to develop and launch solutions for Foliar disease & insect control Shampoos/Conditioners Head-lice treatment challenges facing three key Open field & greenhouses Skin

  5. Slide 5: Our Product Focus

    Our Product Focus ACTIVE INGREDIENTS Our products give growers reduced Our focus is on developing products based on sustainable chemistries to protect crops from pests risk, increased flexibility and security. and disease, with equal or better performance when compared with conventional pesticides A

  6. Slide 6: Products In Action

    Products In Action 6

  7. Slide 7: The Drive Towards Sustainable Agriculture

    The Drive Towards Sustainable Agriculture • Farming practices which maintain yields while increasing benefits for the environment • A reflection of society’s increasing concern about the world’s approach to food production and healthy eating • Embracing farming practices that mimic natural ecologica

  8. Slide 8: Product Characteristics

    Product Characteristics Protecting plants ‘Residue free’ from potentially Tackling damaging chemicals Polymer-free resistance Low or no pre- build-up formulation harvest intervals Enabling sustained technology giving growers delivery, increasing flexibility, security residual efficacy and and contro

  9. Slide 9: The Global Economic Impact of Botrytis

    The Global Economic Impact of Botrytis Botrytis cinerea is one of the most extensively studied fungal pathogens and causes “gray mold” rot in more than 500 plant species Sustainable Control • Mevalone® is used as a preventative $10-100 The annual economic and curative solution for Botrytis cinerea.

  10. Slide 10: High Value Food Crops in Open Field and Greenhouse Environments

    High Value Food Crops in Open Field and Greenhouse Environments The majority of crops in Europe are grown in 1 open field, however, there is an increasing level of investment in greenhouse and glasshouse farming, especially for salad vegetables. The use of greenhouses will help to reduce emissions 2

  11. Slide 11: Eliminating Microplastics in Soil

    Eliminating Microplastics in Soil There is increasing consumer and regulatory pressure to cut 1 out the use of plastic in supply chains. Food production has faced significant scrutiny due to its widespread use of plastics, from farming to packaging. Sustainable Control In farming, microplastics are

  12. Slide 12: Strategy and Investment Case

    Strategy and Investment Case 12

  13. Slide 13: Our Strategy

    Our Strategy BUSINESS LINE RESEARCH, DEVELOPMENT DIVERSIFICATION AND OPERATIONS • Pursuit of opportunities in seed • Supply chain optimisation treatments • Expansion of in-house screening • Development of insecticides and field trials capability • Ongoing work with Elanco Animal • Accelerate commerc

  14. Slide 14: Commercial Footprint

    Commercial Footprint Our presence in Europe grew in 2020 through new authorisations for both Cedroz™ and Mevalone®, and we anticipate further approvals in Europe and further abroad in 2021. Belgium France Total of seven approvals in 2020. Netherlands Spain Albania Serbia Portugal Bulgaria Our US EPA

  15. Slide 15: Significant Market Potential

    Significant Market Potential A growing global market for sustainable products Crop protection products formulated with Sustaine® and Eden’s active ingredients can help address many of these issues: $10 15% $300 Consumer concerns billion per annum million over food safety The global biopesticides The

  16. Slide 16: Enhanced Development Capabilities

    Enhanced Development Capabilities • New offices and laboratories near Oxford – mid 2020: features high-tech equipment to undertake product testing before costly field trials • Development of in-house R&D – reduces dependency on 3rd parties, CROs, etc • In-house capabilities now include formulation,

  17. Slide 17: Seed Treatments

    Seed Treatments Exclusive Commercialisation, Supply and Distribution agreement with Corteva Agriscience

  18. Slide 18: Seed Treatments Key Information

    Seed Treatments Key Information What are Seed Treatments? • Physical, biological or chemical agents applied SEED SEED SEED to seeds to provide protection and help improve overall crop performance DRESSING COATING PELLETING • Multiple functions: supporting greater uniformity of seed germination, plan

  19. Slide 19: Exclusive Agreement with Corteva Agriscience

    Exclusive Agreement with Corteva Agriscience Agreed in May 2021 after a successful multi-year evaluation Highlights of the Agreement: Market Cap £21.5bn • Shared development activities – joint investment of time and resources • Market-facing support from Corteva / Pioneer Seeds Revenue £19.7bn • Pur

  20. Slide 20: Market potential

    Market potential • Eden and Corteva will collaborate on the evaluation of Eden's products and technology in the seed treatment market, which is worth approximately US$6.5 billion annually with an estimated annual growth rate of between 10 and 12 percent. • This project represents Eden’s first foray

  21. Slide 21: 2020 Preliminary Results

    2020 Preliminary Results 21

  22. Slide 22: 2020 Audited Financial Results

    UNIQUE SIGNIFICANT CLEAR SKILLED AND TECHNOLOGY MARKET COMMERCIAL EXPERIENCED POTENTIAL PROGRESS PROFESSIONALS TRAJECTORY OF FINANCIAL GROWTH 2020 AUDITED FINANCIAL RESULTS GPM on product Revenue Cash position sales £1.4m £7.3m 34% (2019: £1.8m) (2019: £0.5m) (2019: 34%) Product sales Operating loss

  23. Slide 23: 2020 Highlights

    SIGNIFICANT UNIQUE SKILLED AND TRAJECTORY MARKET TECHNOLOGY EXPERIENCED OF FINANCIAL POTENTIAL PROFESSIONALS GROWTH CLEAR COMMERCIAL PROGRESS 2020 HIGHLIGHTS • Inclusion of Eden’s three active ingredients, geraniol, eugenol and thymol, in the EU’s Organic Production Regulation • Commencement of a ne

  24. Slide 24: 2020 Highlights (Continued)

    SIGNIFICANT UNIQUE SKILLED AND TRAJECTORY MARKET TECHNOLOGY EXPERIENCED OF FINANCIAL POTENTIAL PROFESSIONALS GROWTH CLEAR COMMERCIAL PROGRESS 2020 HIGHLIGHTS (CONTINUED) • The new authorisation of our bio-fungicide, marketed as Novellus, in Australia • Partnership with M H Poskitt, to develop a new

  25. Slide 25: Post Year End Highlights (2021)

    SIGNIFICANT UNIQUE SKILLED AND TRAJECTORY MARKET TECHNOLOGY EXPERIENCED OF FINANCIAL POTENTIAL PROFESSIONALS GROWTH CLEAR COMMERCIAL PROGRESS POST YEAR END HIGHLIGHTS (2021) • January : Eden received London Stock Exchange's Green Economy Mark which recognises London-listed companies that derive over

  26. Slide 26: Summary & Outlook

    Summary & Outlook 26

  27. Slide 27: Summary of Recent Developments

    Summary of Recent Developments • Fund raise of £10.4m (gross) completed 3/2020 • Awarded Green Economy Mark status by the London Stock Exchange. • New laboratories established near Oxford: in house capabilities replacing contracted services; GLP certification to ensure quality and reduce reliance on

  28. Slide 28: Outlook

    Outlook Strengthened balance sheet following capital raise Moving forward with our new products, including insecticide products, seed treatments and optimised fungicides Additional regulatory approvals expected 2021 with commercial impact in 2021 and beyond In-house work including formulation, micro

  29. Slide 29: Thank you

    Thank you 29

Eden Research — Investor Presentation (June 2021) on 6ix